靶向芳香烃受体以减弱甲状腺眼病中的IGF1R信号传导
本研究探讨芳香烃受体(AHR)激活对甲状腺眼病(TED)眼眶成纤维细胞(OFs)中胰岛素样生长因子1受体(IGF1R)信号的影响。TED OFs的IGF1R和AHR表达升高,IGF1促进增殖、迁移和透明质酸积累;AHR配体FICZ或tapinarof可阻断这些效应,并降低GSK3β磷酸化。作者认为AHR激活是减轻TED进展的有前景的治疗策略。
要点
- TED眼眶成纤维细胞中IGF1R和AHR表达水平较对照升高。
- IGF1促进TED OFs增殖、迁移和透明质酸积累,AHR激活可阻断这些效应。
- AHR通过降低GSK3β磷酸化抑制IGF1R/β-catenin介导的信号通路。
核心结论
- AHR激活通过抑制IGF1R信号传导,可能成为减轻TED进展的有前景的治疗策略。
研究设计与样本
- 实验研究:检测TED、非TED和非OF对照中IGF1R与AHR表达,用增殖、透明质酸积累和迁移实验分析OF激活,RNA测序检测IGF1处理TED OFs的转录组变化,并以AHR配体FICZ或tapinarof处理OFs(有或无IGF1),Western blotting评估信号通路。
主要发现
- TED OFs的IGF1R和AHR表达水平较对照升高。
- IGF1较非TED OFs显著增加TED OFs的透明质酸积累、增殖和迁移。
- IGF1R信号改变TED OFs中数百个控制细胞迁移、增殖和代谢的基因表达,包括TUBA1B、TUBA1C、CRABP2上调,IRS2和SOD3下调。
- AHR激活阻断由IGF1R信号介导的增殖、迁移、透明质酸产生和基因表达。
- AHR通过降低GSK3β磷酸化抑制上述通路,GSK3β是IGF1R/β-catenin介导信号的重要介质。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Thyroid eye disease (TED) is an autoimmune disorder characterized by proptosis, inflammation, and fibrosis. Elevated insulin-like growth factor 1 receptor (IGF1R) signaling in TED orbital fibroblasts (OFs) drives the proliferation and biosynthesis of hyaluronan, which causes enlargement of orbital tissue volume. The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that regulates cellular stress responses, metabolism, and inflammation. Given its important role in regulating cellular responses, we hypothesized that activation of the AHR could limit excessive IGF1R signaling in TED OFs, offering therapeutic potential. Methods: We measured IGF1R and AHR expression levels in TED, non-TED, and non-OF controls. OF activation was analyzed using proliferation, hyaluronan accumulation, and migration assays. RNA sequencing was used to detect transcriptome-wide changes in IGF1-treated TED OFs. After gene set enrichment analysis, select gene expression changes were validated by quantitative polymerase chain reaction. OFs were treated with the AHR ligands 6-formylindolo[3,2-b]carbazole (FICZ) or tapinarof with or without IGF1. Western blotting evaluated signaling pathways impacted by AHR and IGF1R signaling. Results: TED OFs showed elevated IGF1R and AHR expression levels compared to controls. IGF1 significantly increased hyaluronan accumulation, proliferation, and migration in TED OFs compared to non-TED OFs. IGF1R signaling altered the expression of hundreds of genes controlling cell migration, proliferation, and metabolism in TED OFs. These genes included TUBA1B, TUBA1C, CRABP2 (upregulated), and IRS2 and SOD3 (downregulated). AHR activation blocked proliferation, migration, hyaluronan production, and gene expression mediated through IGF1R signaling. The AHR inhibited these pathways by reducing phosphorylation of GSK3β, an important mediator of IGF1R/β-catenin mediated signaling. Conclusions: AHR activation represents a promising therapeutic strategy for mitigating TED progression by inhibiting IGF1R signaling. Through modulation of GSK3β-mediated pathways, AHR activation may target additional pathologically relevant pathways beyond those affected by direct IGF1R inhibitors. This research provides novel insights into TED pathophysiology and offers a potential avenue for developing therapies to improve patient outcomes.
引用
- Roztocil E, Husain F, Patrick CC, et al. Targeting the Aryl Hydrocarbon Receptor to Attenuate IGF1R Signaling in Thyroid Eye Disease. Thyroid. 2025. PMID: 40257057. doi:10.1089/thy.2024.0529
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。